Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enver Akalin

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Progress in Transplantation (Aliso Viejo, Calif.)|September 20, 2019
Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral AgentsJay A Graham, Maria Ajaimy, Jin Carrero, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 21, 2025
Proof of Concept that Implementation of a Multispecialty Educational Intervention May Improve Acceptance of Organs from Donors with HIV at a Tertiary Care Hospital: A Single-Center StudyNeeraja Swaminathan, Yoram A Puius, Jonathan Czeresnia, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 11, 2025
Increased Treg in Kidney Transplant Recipients With ErythrocytosisCarolina Bigatti, Sadia Mustofa, Dana Korogodsky, et al.
Transplantation|January 26, 2010
The variable pathology of kidney disease after liver transplantationJin-Yon Kim, Enver Akalin, Steven Dikman, et al.
Clinical Transplantation|December 23, 2018
Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibodyMichelle Lubetzky, Nicole Hayde, Pilib Ó Broin, et al.
Transplantation|December 24, 2016
Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral AgentsMichelle Lubetzky, Soohwan Chun, Andrew Joelson, et al.
Clinical Transplantation|July 24, 2009
Differential outcomes in 3 types of acute antibody-mediated rejectionMuhammad A Rafiq, Graciela de Boccardo, Bernd Schröppel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Diabetes Research and Clinical Practice|May 23, 2020
Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective studySandra Aleksic, Ruth Eisenberg, Effie Tsomos, et al.
Transplantation|December 7, 2013
Genomics of BK viremia in kidney transplant recipientsMichelle Lubetzky, Yi Bao, Pilib O Broin, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Progress in Transplantation (Aliso Viejo, Calif.)|September 20, 2019
Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral AgentsJay A Graham, Maria Ajaimy, Jin Carrero, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 21, 2025
Proof of Concept that Implementation of a Multispecialty Educational Intervention May Improve Acceptance of Organs from Donors with HIV at a Tertiary Care Hospital: A Single-Center StudyNeeraja Swaminathan, Yoram A Puius, Jonathan Czeresnia, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 11, 2025
Increased Treg in Kidney Transplant Recipients With ErythrocytosisCarolina Bigatti, Sadia Mustofa, Dana Korogodsky, et al.
Transplantation|January 26, 2010
The variable pathology of kidney disease after liver transplantationJin-Yon Kim, Enver Akalin, Steven Dikman, et al.
Clinical Transplantation|December 23, 2018
Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibodyMichelle Lubetzky, Nicole Hayde, Pilib Ó Broin, et al.
Transplantation|December 24, 2016
Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral AgentsMichelle Lubetzky, Soohwan Chun, Andrew Joelson, et al.
Clinical Transplantation|July 24, 2009
Differential outcomes in 3 types of acute antibody-mediated rejectionMuhammad A Rafiq, Graciela de Boccardo, Bernd Schröppel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Diabetes Research and Clinical Practice|May 23, 2020
Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective studySandra Aleksic, Ruth Eisenberg, Effie Tsomos, et al.
Transplantation|December 7, 2013
Genomics of BK viremia in kidney transplant recipientsMichelle Lubetzky, Yi Bao, Pilib O Broin, et al.
Pageof 14